DG
6
2
MCHP
41
4
SYY
53
4
LRCX
43
-2
COF
60
2
WEC
53
-2
URI
65
5
DD
63
3
AON
54
2
XRX
44
3
ZION
65
2
HCA
44
-2
NWL
53
3
DFS
64
2
BBY
46
10
TXT
55
3
MSFT
50
3
KMB
39
2
GIS
31
3
SLB
55
2
DG
6
2
MCHP
41
4
SYY
53
4
LRCX
43
-2
COF
60
2
WEC
53
-2
URI
65
5
DD
63
3
AON
54
2
XRX
44
3
ZION
65
2
HCA
44
-2
NWL
53
3
DFS
64
2
BBY
46
10
TXT
55
3
MSFT
50
3
KMB
39
2
GIS
31
3
SLB
55
2
Financhill
Back

Moleculin Biotech Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell
31

MBRX
Moleculin Biotech

Last Price:
2.90
Seasonality Move:
-7.93%
Sell
28

NBY
NovaBay Pharmaceuticals

Last Price:
0.69
Seasonality Move:
-0.57%
Sell
31
Moleculin Biotech (MBRX) is a Sell

Is Moleculin Biotech a Buy, Sell or Hold?

  • The current Moleculin Biotech [MBRX] share price is $2.73. The Score for MBRX is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • MBRX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
28
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.68. The Score for NBY is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

MBRX Stock Price Chart

What is Moleculin Biotech's stock price today?

  • The Moleculin Biotech share price today is $2.73
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MBRX is experiencing selling pressure, which indicates risk of future bearish movement.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.68
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing selling pressure, which indicates risk of future bearish movement.

MBRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.06 Buy
Relative Strength Index (14 RSI): 53.79 Buy
Chaikin Money Flow: -23304 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.43 - 2.73) Buy
Bollinger Bands (100): (2.18 - 3.3) Sell

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.01 Buy
Relative Strength Index (14 RSI): 48.48 Sell
Chaikin Money Flow: -30586 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.61 - 0.75) Buy
Bollinger Bands (100): (0.28 - 1.42) Sell

MBRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.71 Buy
20-day SMA: 2.59 Buy
50-day SMA: 2.54 Buy
200-day SMA: 4.25 Sell
8-day EMA: 2.69 Buy
20-day EMA: 2.62 Buy
50-day EMA: 2.62 Buy
200-day EMA: 4.29 Sell

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.71 Sell
20-day SMA: 0.71 Sell
50-day SMA: 0.66 Buy
200-day SMA: 2.33 Sell
8-day EMA: 0.71 Sell
20-day EMA: 0.7 Sell
50-day EMA: 0.73 Sell
200-day EMA: 5.57 Sell

Moleculin Biotech Earnings Growth & MBRX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.06 per share, and an increase next year of $8.81 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.

Moleculin Biotech Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):